Evidence map›Paper›PMID 15367396›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2005

Reducing plasma HIV RNA improves muscle amino acid metabolism.

Kevin E Yarasheski, Samuel R Smith, William G Powderly

Abstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Age attenuates leucine oxidation after eccentric exercise.International journal of sports medicine · 2013
    Article
  12. Article
  13. Article
  14. Article
  15. Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals.The journals of gerontology. Series A, Biological sciences and medical sciences · 2011
    Article
  16. Evaluation of early biomarkers of muscle anabolic response to testosterone.Journal of cachexia, sarcopenia and muscle · 2011
    Article
  17. Skeletal and cardiac myopathy in HIV-1 transgenic rats.American journal of physiology. Endocrinology and metabolism · 2008
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kevin E YarasheskiDepartment of Internal Medicine, Division of Metabolism, Endocrinology & Lipid Research, Washington University School of Medicine, St. Louis, MO 63110, USA. key@im.wustl.edu
Samuel R Smith
William G Powderly
Washington University in St. Louis · US

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Brian N Finck · 1999 to 2026
$30.2M
YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMESM01RR000036 · NCRR · WASHINGTON UNIVERSITY · PI NEWCOMER, JOHN W. · 1985 to 2007
$25.4M
YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTSP41RR000954 · NCRR · WASHINGTON UNIVERSITY · PI GROSS, MICHAEL L · 1985 to 2011
$16.0M
WOMEN'S HEALTH AGENDAU01AI025903 · NIAID · WASHINGTON UNIVERSITY · PI CLIFFORD, DAVID B · 1987 to 2006
$12.5M
Myocardial Function /FFA Metabolism in HIV Metabolic SynR01DK059531 · NIDDK · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2000 to 2008
$3.8M
PROTEIN TURNOVER AND ANABOLIC INTERVENTIONS IN AIDSR01DK049393 · NIDDK · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 1994 to 2008
$2.2M
MUSCLE AMINO ACID METABOLISM IN AIDS CACHEXIAR01DK054163 · NIDDK · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 1998 to 2002
$1.1M
EXERCISE AND PIOGLITAZONE FOR HIV CARDIOMETABOLIC SYNDROMESR56DK049393 · NIDDK · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2009 to 2009
$500k
NCRR NIH HHS M01 RR000036NCRR NIH HHS P41 RR000954NCRR NIH HHS RR-00036NCRR NIH HHS RR-00954NIAID NIH HHS AI-25903NIAID NIH HHS U01 AI025903NIDDK NIH HHS DK-49393NIDDK NIH HHS DK-54163NIDDK NIH HHS DK-56341NIDDK NIH HHS DK-59531NIDDK NIH HHS P30 DK056341NIDDK NIH HHS R01 DK049393NIDDK NIH HHS R01 DK054163NIDDK NIH HHS R01 DK059531NIDDK NIH HHS R56 DK049393
6 · The paper itself

Abstract

We reported (Yarasheski KE, Zachwieja JJ, Gischler J, Crowley J, Horgan MM, and Powderly WG. Am J Physiol Endocrinol Metab 275: E577-E583, 1998) that AIDS muscle wasting was associated with an inappropriately low rate of muscle protein synthesis and an elevated glutamine rate of appearance (Ra Gln). We hypothesized that high plasma HIV RNA caused dysregulation of muscle amino acid metabolism. We determined whether a reduction in HIV RNA (> or =1 log) increased muscle protein synthesis rate and reduced R(a) Gln and muscle proteasome activity in 10 men and 1 woman (22-57 yr, 60-108 kg, 17-33 kg muscle) with advanced HIV (CD4 = 0-311 cells/microl; HIV RNA = 10-375 x 10(3) copies/ml). We utilized stable isotope tracer methodologies ([13C]Leu and [15N]Gln) to measure the fractional rate of mixed muscle protein synthesis and plasma Ra Gln in these subjects before and 4 mo after initiating their first or a salvage antiretroviral therapy regimen. After treatment, median CD4 increased (98 vs. 139 cells/microl, P = 0.009) and median HIV RNA was reduced (155,828 vs. 100 copies/ml, P = 0.003). Mixed muscle protein synthesis rate increased (0.062 +/- 0.005 vs. 0.078 +/- 0.006%/h, P = 0.01), Ra Gln decreased (387 +/- 33 vs. 323 +/- 15 micromol.kg fat-free mass(-1).h(-1), P = 0.04), and muscle proteasome chymotrypsin-like catalytic activity was reduced 14% (P = 0.03). Muscle mass was only modestly increased (1 kg, P = not significant). We estimated that, for each 10,000 copies/ml reduction in HIV RNA, approximately 3 g of additional muscle protein are synthesized per day. These findings suggest that reducing HIV RNA increases muscle protein synthesis and reduces muscle proteolysis, but muscle protein synthesis relative to whole body protein synthesis rate is not restored to normal, so muscle mass is not substantially increased.

Indexed as

AdultAmino AcidsAntiretroviral Therapy, Highly ActiveBody CompositionCarbon IsotopesChymotrypsinEndopeptidasesFemaleHIVHIV InfectionsHumansMaleMiddle AgedMuscle, SkeletalMuscular AtrophyNitrogen IsotopesAmino AcidsCarbon IsotopesChymotrypsinEndopeptidasesNitrogen Isotopespeptidylglutamylpeptide hydrolaseRNA, ViralTrypsin

Identifiers

PMID15367396
PMCPMC3170408
OpenAlexW2090458598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.